Edwards Lifesciences Corp (EW) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for Edwards Lifesciences Corp (EW): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 59/100 — a percentile rank of Edwards Lifesciences Corp’s fundamentals against Manufacturing peers, weakest on valuation. A quality ranking, not a price prediction.
| Market cap | $49.1B |
| P / E | 48.9× |
| P / S | 7.5× |
| EV / EBITDA | 23.6× |
| Gross margin | 77.8% |
| Operating margin | 21.8% |
| Net margin | 15.4% |
| Return on equity | 9.5% |
| ROIC | 11.7% |
| Revenue growth | 14.6% |
| Debt / equity | 0.1× |
| Dividend yield | 0.0% |
Is Edwards Lifesciences Corp overvalued? P/E looks overvalued vs its 5-year range; P/S looks undervalued vs its 5-year range; EV/EBITDA looks undervalued vs its 5-year range; P/B looks fair vs its 5-year range.
Independent of the events above — derived from Edwards Lifesciences Corp’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact